Pharmacokinetics of Ceftaroline in Normal and Obese Subjects
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to characterize plasma and urinary concentrations of ceftaroline
following intravenous administration of a single dose of ceftaroline 600 mg in healthy
subjects who are normal weight, overweight, and obese.